159 related articles for article (PubMed ID: 11166957)
21. Silencing hypoxia-inducible factor-1alpha inhibits cell migration and invasion under hypoxic environment in malignant gliomas.
Fujiwara S; Nakagawa K; Harada H; Nagato S; Furukawa K; Teraoka M; Seno T; Oka K; Iwata S; Ohnishi T
Int J Oncol; 2007 Apr; 30(4):793-802. PubMed ID: 17332917
[TBL] [Abstract][Full Text] [Related]
22. Glioma invasion in vitro: regulation by matrix metalloprotease-2 and protein kinase C.
Uhm JH; Dooley NP; Villemure JG; Yong VW
Clin Exp Metastasis; 1996 Oct; 14(5):421-33. PubMed ID: 8871536
[TBL] [Abstract][Full Text] [Related]
23. The essential roles of matrix metalloproteinase-2, membrane type 1 metalloproteinase and tissue inhibitor of metalloproteinase-2 in the invasive capacity of acute monocytic leukemia SHI-1 cells.
Wang C; Chen Z; Li Z; Cen J
Leuk Res; 2010 Aug; 34(8):1083-90. PubMed ID: 20138666
[TBL] [Abstract][Full Text] [Related]
24. Gelatinolytic activity of matrix metalloproteinase-2 and matrix metalloproteinase-9 in rat brain after implantation of 9L rat glioma cells.
Zhao JX; Yang LP; Wang YF; Qin LP; Liu DQ; Bai CX; Nan X; Shi SS; Pei XJ
Eur J Neurol; 2007 May; 14(5):510-6. PubMed ID: 17437609
[TBL] [Abstract][Full Text] [Related]
25. Stimulation of extracellular matrix components in the normal brain by invading glioma cells.
Knott JC; Mahesparan R; Garcia-Cabrera I; Bølge Tysnes B; Edvardsen K; Ness GO; Mørk S; Lund-Johansen M; Bjerkvig R
Int J Cancer; 1998 Mar; 75(6):864-72. PubMed ID: 9506531
[TBL] [Abstract][Full Text] [Related]
26. Testican 2 abrogates inhibition of membrane-type matrix metalloproteinases by other testican family proteins.
Nakada M; Miyamori H; Yamashita J; Sato H
Cancer Res; 2003 Jun; 63(12):3364-9. PubMed ID: 12810672
[TBL] [Abstract][Full Text] [Related]
27. Invadopodia: at the cutting edge of tumour invasion.
Stylli SS; Kaye AH; Lock P
J Clin Neurosci; 2008 Jul; 15(7):725-37. PubMed ID: 18468901
[TBL] [Abstract][Full Text] [Related]
28. Tumor cell invasion through matrigel is regulated by activated matrix metalloproteinase-2.
Deryugina EI; Luo GX; Reisfeld RA; Bourdon MA; Strongin A
Anticancer Res; 1997; 17(5A):3201-10. PubMed ID: 9413149
[TBL] [Abstract][Full Text] [Related]
29. The role of matrix metalloproteinase genes in glioma invasion: co-dependent and interactive proteolysis.
VanMeter TE; Rooprai HK; Kibble MM; Fillmore HL; Broaddus WC; Pilkington GJ
J Neurooncol; 2001 Jun; 53(2):213-35. PubMed ID: 11716072
[TBL] [Abstract][Full Text] [Related]
30. Effect of phorbol ester and cytokines on matrix metalloproteinase and tissue inhibitor of metalloproteinase expression in tumor and normal cell lines.
Mackay AR; Ballin M; Pelina MD; Farina AR; Nason AM; Hartzler JL; Thorgeirsson UP
Invasion Metastasis; 1992; 12(3-4):168-84. PubMed ID: 1284126
[TBL] [Abstract][Full Text] [Related]
31. Differential expression and localization of TIMP-1 and TIMP-4 in human gliomas.
Groft LL; Muzik H; Rewcastle NB; Johnston RN; Knäuper V; Lafleur MA; Forsyth PA; Edwards DR
Br J Cancer; 2001 Jul; 85(1):55-63. PubMed ID: 11437402
[TBL] [Abstract][Full Text] [Related]
32. Localization of matrix metalloproteinases-1, -2, and -9 and tissue inhibitor of metalloproteinase-2 in interstitial lung diseases.
Fukuda Y; Ishizaki M; Kudoh S; Kitaichi M; Yamanaka N
Lab Invest; 1998 Jun; 78(6):687-98. PubMed ID: 9645759
[TBL] [Abstract][Full Text] [Related]
33. Molecular determinants of glioma cell migration and invasion.
Wild-Bode C; Weller M; Wick W
J Neurosurg; 2001 Jun; 94(6):978-84. PubMed ID: 11409528
[TBL] [Abstract][Full Text] [Related]
34. Molecular characterization of cell substratum attachments in human glial tumors relates to prognostic features.
Belot N; Rorive S; Doyen I; Lefranc F; Bruyneel E; Dedecker R; Micik S; Brotchi J; Decaestecker C; Salmon I; Kiss R; Camby I
Glia; 2001 Dec; 36(3):375-90. PubMed ID: 11746774
[TBL] [Abstract][Full Text] [Related]
35. Role of tissue inhibitor of metalloproteinases-2 (TIMP-2) in regulation of pro-gelatinase A activation catalyzed by membrane-type matrix metalloproteinase-1 (MT1-MMP) in human cancer cells.
Shofuda K; Moriyama K; Nishihashi A; Higashi S; Mizushima H; Yasumitsu H; Miki K; Sato H; Seiki M; Miyazaki K
J Biochem; 1998 Aug; 124(2):462-70. PubMed ID: 9685743
[TBL] [Abstract][Full Text] [Related]
36. Matrix metalloproteinases in human melanoma cell lines and xenografts: increased expression of activated matrix metalloproteinase-2 (MMP-2) correlates with melanoma progression.
Hofmann UB; Westphal JR; Waas ET; Zendman AJ; Cornelissen IM; Ruiter DJ; van Muijen GN
Br J Cancer; 1999 Nov; 81(5):774-82. PubMed ID: 10555745
[TBL] [Abstract][Full Text] [Related]
37. The influence of sequential, in vitro passage on secretion of matrix metalloproteinases by human brain tumour cells.
Rossi M; Rooprai HK; Maidment SL; Rucklidge GJ; Pilkington GJ
Anticancer Res; 1996; 16(1):121-8. PubMed ID: 8615596
[TBL] [Abstract][Full Text] [Related]
38. Matrix metalloproteinase 2 from human rheumatoid synovial fibroblasts. Purification and activation of the precursor and enzymic properties.
Okada Y; Morodomi T; Enghild JJ; Suzuki K; Yasui A; Nakanishi I; Salvesen G; Nagase H
Eur J Biochem; 1990 Dec; 194(3):721-30. PubMed ID: 2269296
[TBL] [Abstract][Full Text] [Related]
39. PTEN gene transfer suppresses the invasive potential of human malignant gliomas by regulating cell invasion-related molecules.
Furukawa K; Kumon Y; Harada H; Kohno S; Nagato S; Teraoka M; Fujiwara S; Nakagawa K; Hamada K; Ohnishi T
Int J Oncol; 2006 Jul; 29(1):73-81. PubMed ID: 16773187
[TBL] [Abstract][Full Text] [Related]
40. BCL-2 promotes migration and invasiveness of human glioma cells.
Wick W; Wagner S; Kerkau S; Dichgans J; Tonn JC; Weller M
FEBS Lett; 1998 Dec; 440(3):419-24. PubMed ID: 9872414
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
